Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143236 |
| CAS No | NA |
| Mol.F. | C31H32N4O7S |
| Mol.Wt. | 604.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143237 |
| CAS No | NA |
| Mol.F. | C27H26N4O7S |
| Mol.Wt. | 550.59 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143238 |
| CAS No | NA |
| Mol.F. | C46H48N6O9S |
| Mol.Wt. | 860.98 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143239 |
| CAS No | NA |
| Mol.F. | C47H47N5O11S2 |
| Mol.Wt. | 922.04 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143240 |
| CAS No | NA |
| Mol.F. | C20H23ClN2O2 |
| Mol.Wt. | 358.9 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143241 |
| CAS No | NA |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143242 |
| CAS No | NA |
| Mol.F. | C20H23ClN2O2 |
| Mol.Wt. | 358.9 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143243 |
| CAS No | NA |
| Mol.F. | C14H12N2O4 |
| Mol.Wt. | 272.26 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143244 |
| CAS No | NA |
| Mol.F. | C14H11ClN2O2 |
| Mol.Wt. | 274.70 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143245 |
| CAS No | NA |
| Mol.F. | C15H10ClN3O3 |
| Mol.Wt. | 315.71 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143246 |
| CAS No | NA |
| Mol.F. | C16H12ClN3O3 |
| Mol.Wt. | 329.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143247 |
| CAS No | NA |
| Mol.F. | C19H19FN2O4 |
| Mol.Wt. | 358.37g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143248 |
| CAS No | NA |
| Mol.F. | C21H24N2O5 |
| Mol.Wt. | 384.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143249 |
| CAS No | NA |
| Mol.F. | C20H22N2O5 |
| Mol.Wt. | 370.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143250 |
| CAS No | NA |
| Mol.F. | C19H19FN2O4 |
| Mol.Wt. | 358.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143251 |
| CAS No | NA |
| Mol.F. | C17H23ClN4O4 |
| Mol.Wt. | 382.85 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |